Jump to content

Dapiprazole

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 69.40.50.59 (talk) at 04:44, 2 August 2017 (Another drug that is now in commercial use can be mistaken with either agent.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dapiprazole
Clinical data
AHFS/Drugs.comConsumer Drug Information
MedlinePlusa601043
Pregnancy
category
  • B
Routes of
administration
Topical (eye drops)
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityNegligible when administered topically
Identifiers
  • 3-{2-[4-(2-methylphenyl)piperazin-1-yl]ethyl}-5,6,7,8-
    tetrahydro-[1,2,4]triazolo[4,5-a]pyridine
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H27N5
Molar mass325.451 g/mol g·mol−1
3D model (JSmol)
  • n1nc(n2c1CCCC2)CCN4CCN(c3ccccc3C)CC4
  • InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3 checkY
  • Key:RFWZESUMWJKKRN-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Dapiprazole (Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination.[1]

References

  1. ^ Doughty, Michael J.; Lyle, William M. (May 1992). "A Review of the Clinical Pharmacokinetics of Pilocarpine, Moxisylyte (Thymoxamine), and Dapiprazole in the Reversal of Diagnostic Pupillary Dilation". Optometry & Vision Science. 69 (5).